Sort by:

select Language:

Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA

European Centre for Disease Prevention and Control, (2018)

The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended to support EU/EEA Member States to develop national strategies to strengthen infectious disease prevention and control among migrants and meet the health needs of these populations.

Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis

World Health Organization WHO, (2018)

2nd edition. T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or symptoms of TB in seeking diagnosis, treatment and care; and includes key algorithms and cross-cutting elements that are essential to a patient-centered approach in the cascade of TB care. The Compendium is structured into 33 WHO standards and consolidates all current WHO TB policy recommendations into a single resource, with electronic links to the individual, comprehensive WHO policy guidelines

Mejores prácticas para la atención de pacientes con tuberculosis

G. Williams, E. Alarcón, S. Jittimanee et al., (2017)

Guía para países de bajos ingresos. 2 edición

Field Guide for the Management of Drug-Resistant Tuberculosis

A. Piubello, Eds.: The International Union Against Tuberculosis and Lung Disease, (2018)

A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.

Management of Diabetes Mellitus-Tuberculosis – A Guide to the Essential Practice

Lin Yan, Anthony D Harries, Ajay M V Kumar, et al., Eds.: The International Union Against Tuberculosis and Lung Disease, (2018)

This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation.

Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries

G. Williams, E. Alarcón, S. Jittimanee et al., Eds.: The International Union Against Tuberculosis and Lung Disease, (2017)

2nd edition. The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide

Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Policy brief

World Health Organization WHO, (2018)

Cryptococcal meningitis is a serious opportunistic infection which is a major cause of morbidity and mortality in people living with HIV with advanced disease, accounting for an estimated 15% of all AIDS-related deaths globally. An estimated 223,100 cases of cryptococcal meningitis result in 181,000 deaths each year among people living with HIV. Cryptococcal disease is rare in children with HIV, even in areas with a high disease burden among adults

World Health Organization. Typhoid vaccines: WHO position paper.

World Health Organization WHO, (2018)

Accessed Sept, 5 2018 Weekly epidemiological record, Relevé épidémiologique hebdomadaire : Vol.93 (2018) No.13

Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)

World Health Organization WHO, (2018)

The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked medicines for all patients with MDR-TB.

307 hits